cardiac troponin T (cTnT) antibody and antigen (Recombinant protein)

Diagnostic cardiac troponin T (cTnT) antibodies (anti-cardiac troponin T, anti-cTnT) and antigens (recombinant cardiac troponin T (cTnT) protein) for Cardiovascular disease cTnT detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-h-cTnT-Ag01 Recombinant human TNNT2/cTnT Protein 3090
GMP-h-cTnT-Ab01 Anti-human TNNT2/cTnT mouse monoclonal antibody (mAb) 1953
GMP-h-cTnT-Ab02 Anti-human TNNT2/cTnT mouse monoclonal antibody (mAb) 1953
GMP-h-cTnT-Ab03 Anti-human TNNT2/cTnT human monoclonal antibody (mAb) 1953
GMP-h-cTnT-Ab04 Anti-human TNNT2/cTnT human monoclonal antibody (mAb) 1953

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-h-cTnT-Ag01
Product Name Recombinant human TNNT2/cTnT Protein
Target/Biomarker cardiac troponin T (cTnT)
Alias of Target/Biomarker CMD1D, CMH2, CMPD2, LVNC6, RCM3, TnTC, cTnT
Expression platform mammalian
Isotypes Recombinant Antigen
Bioactivity validation cardiac troponin T (cTnT) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in cTnT level test of Cardiovascular disease (hypertrophic cardiomyopathy, restrictive and dilated cardiomyopathy. ) and related syndrome evaluation.
Tag His
Products description Recombinant human TNNT2/cTnT Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-h-cTnT-Ab01, GMP-h-cTnT-Ab02
Product Name Anti-human TNNT2/cTnT mouse monoclonal antibody (mAb)
Target/Biomarker cardiac troponin T (cTnT)
Alias of Target/Biomarker CMD1D, CMH2, CMPD2, LVNC6, RCM3, TnTC, cTnT
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation cardiac troponin T (cTnT) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in cTnT level test of Cardiovascular disease (hypertrophic cardiomyopathy, restrictive and dilated cardiomyopathy. ) and related syndrome evaluation.
Tag mFc
Products description Anti-human TNNT2/cTnT mouse monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-h-cTnT-Ab03, GMP-h-cTnT-Ab04
Product Name Anti-human TNNT2/cTnT human monoclonal antibody (mAb)
Target/Biomarker cardiac troponin T (cTnT)
Alias of Target/Biomarker CMD1D, CMH2, CMPD2, LVNC6, RCM3, TnTC, cTnT
Expression platform CHO
Isotypes Human lgG1
Bioactivity validation cardiac troponin T (cTnT) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in cTnT level test of Cardiovascular disease (hypertrophic cardiomyopathy, restrictive and dilated cardiomyopathy. ) and related syndrome evaluation.
Tag hFc
Products description Anti-human TNNT2/cTnT human monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    cTnT) is a protein that in humans is encoded by the TNNT2 gene. Cardiac TnT is the tropomyosin-binding subunit of the troponin complex, which is located on the thin filament of striated muscles and regulates muscle contraction in response to alterations in intracellular calcium ion concentration.As part of the Troponin complex, the function of cTnT is to regulate muscle contraction. The N-terminal region of TnT that strongly binds actin most likely moves with Tm and actin during strong myosin crossbridge binding and force generation. This region is likely involved in the transduction of cooperativity down the thin filament.[14] The C-terminal region of TnT constitutes part of the globular troponin complex domain, and participates in employing the calcium sensitivity of strong myosin crossbridge binding to the thin filament.[15]Mutations in this gene have been associated with familial hypertrophic cardiomyopathy as well as with restrictive[16] and dilated cardiomyopathy. Transcripts for this gene undergo alternative splicing that results in many tissue-specific isoforms, however, the full-length nature of some of these variants has not yet been determined.[17] Mutations of this gene may be associated with mild or absent hypertrophy and predominant restrictive disease, with a high risk of sudden cardiac death.[16] Advancement to dilated cardiomyopathy may be more rapid in patients with TNNT2 mutations than in those with myosin heavy chain mutations.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    Richard Davis 2023-12-26 11:05:29
    This cTnT antibody has good stability and data quality for Lateral Flow Immunoassay (LFIA). Its stable operation contributes to proper identification of the problem.

    Leave a comment